18 May 2022 | BST (UTC+1)
Preclinical Immuno-Oncology
18 May 2022 | BST (UTC+1)

Covering key areas of interest within preclinical immuno-oncology, this interactive online conference is designed for immunotherapy experts to stay up to date with the latest models and approaches impacting their workflow. Discuss innovative approaches to preclinical development, with a focus on preventing translational failures through the development of predictive and robust preclinical models.

Programme

Benefits to Attending...

  • Covering key areas of interest within preclinical immuno-oncology, this interactive online conference is designed for immunotherapy experts to stay up to date with the latest models and approaches impacting their workflow
  • Discuss innovative approaches to preclinical development, with a focus on preventing translational failures through the development of predictive & robust preclinical models
  • Benefit from additional sessions on preclinical challenges, including safety & efficacy considerations
  • Interact with fellow attendees and speakers during the live group Q&As, allowing you to join the conversation and pose your questions to our panel of experts

Agenda at a Glance

  • Advanced model selection to ensure clinical success:
       » Humanised mouse models
       » Syngeneic & Xenographic models
       » 3D Models & Organoids
  • Leveraging predictive and physiologically relevant cellular and animal models
  • How can cutting-edge preclinical models impact biomarker identification
  • Improving success rates in the clinic
  • Preclinical case studies from leading immunotherapy companies – cell therapies, antibodies, oncolytic viruses
  • Preclinical identification and validation of immuno-oncology targets
  • Preclinical strategies for combination therapies
  • Improving safety & overcoming toxicity challenge
  • Novel exploratory and translational biomarkers impacting preclinical research
  • Emerging clinical assays to advance new agent discovery & development, and to improve patient outcomes
  • Predictive biomarkers of response, toxicity and resistance to immunotherapy
  • Liquid biopsies in immuno-oncology

Key Speakers

Preclinical Immuno-Oncology: Online brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook

Below are some of our confirmed speakers for Preclinical Immuno-Oncology: Online 2022

Peter Joyce
Chief Executive Officer
Grey Wolf Therapeutics
Dirk Brockstedt
Chief Scientific Officer
RAPT Therapeutics
Thierry Guillaudeux
Senior Vice President, Immuno-Oncology
Kineta, Inc.
Genevive Hernandez
Senior Director, Clinical Biomarkers, Clinical Research and Development
IGM Biosciences
Stephanie Casey Parks
Senior Scientist, Pharmacology
Amgen
Pravin Kaumaya
Professor
Ohio State University

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.

Live and On-Demand Presentations

Benefit from the insight of our expert speakers via pre-recorded presentations and interactive live presentations

Virtual Conference Platform

Our fully featured platform offers an immersive conference experience, delivering all the benefits of an in-person event

Digital Networking Opportunities

Connect directly with other registrants of event around the world through direct 1-2-1 chat, video chat and group discussion

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure